Abdula, Al Asher M.
HRN: 21-99-27 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/07/2023
CEFUROXIME 750MG (VIAL)
09/07/2023
09/14/2023
IV
250mg
Q8hours
PCAP
Checking Final Appropriateness
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes